Statistically significant improvements in primary endpoint of ammonia control compared with placebo at 36 weeksClinically important changes ...
March 12 (Reuters) - Ultragenyx Pharmaceutical said on Thursday its experimental gene therapy helped patients in a late-stage trial to better control ammonia levels linked to a rare inherited disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results